Sonoma Pharmaceuticals Inc. (SNOA)

Sonoma Pharmaceuticals Inc. Azioni (SNOA) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	14.90% 3.138	2.731	3.427	3.014	2.944
Cost Of Revenue	3.62% 1.678	1.741	2.223	2.15	2.113
Gross Profit	47.47% 1.46	0.99	1.204	0.864	0.831
Operating Expenses	4.82% 2.304	2.198	2.444	2.011	2.665
Benefits Costs and Expenses	0.79% 4.061	4.029	4.878	4.453	4.849
Costs And Expenses	0.79% 4.061	4.029	4.878	4.453	4.849
Operating Income/Loss	30.13% -0.844	-1.208	-1.24	-1.147	-1.834
Income/Loss From Continuing Operations Before Tax	28.89% -0.923	-1.298	-1.451	-1.439	-1.905
Income Tax Expense/Benefit, Deferred	196.30% -0.052	0.054	0.09	-	-
Income Tax Expense/Benefit	130.65% -0.057	0.186	-0.033	-0.131	0.034
Income/Loss From Continuing Operations After Tax	41.64% -0.866	-1.484	-1.418	-1.308	-1.939
Net Income/Loss	41.64% -0.866	-1.484	-1.418	-1.339	-1.939
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-0.031	-
Basic Average Shares	211.15K% 10.91	0.00516	0.00494	0.00029	0.00311
Diluted Average Shares	211.15K% 10.91	0.00516	0.00494	0.00029	0.00311
Basic Earnings Per Share	72.41% -0.08	-0.29	-0.29	-0.28	-0.62
Diluted Earnings Per Share	72.41% -0.08	-0.29	-0.29	-0.28	-0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-